Efficacy and tolerability of tasipimidine after 3 repeated bed-time doses in patients with insomnia disorder with a 4-week extension part

Wake after sleep onset (WASO) assessed with polysomnography (PSG) for Day 1 and Day 2 data combined from Part 1 and Part 2, Latency to persistent sleep (LPS) assessed with polysomnography (PSG) for Day 1 and Day 2 data combined from Part 1 and Part 2